Dr Darshan R S

Dr Darshan R S

Consultant Medical and Hemato Oncologist

Dr. Darshan R S is a Consultant in Medical Oncology at Cancer Therapy India, specializing in cancer diagnosis, chemotherapy, immunotherapy, targeted therapy, and personalized cancer care. He focuses on evidence-based treatment plans with compassionate support, helping patients manage complex cancer conditions effectively.

Qualifications
  • MBBS (2011-2015)- RAICHUR INSTITUTE OF MEDICAL SCIENCES, RAICHUR, KARNATAKA- 584102.
  • MD General Medicine (2018-2021) at RNT MEDICAL COLLEGE, UDAIPUR, RAJASTHAN- 313001.
  • Pursing DM MEDICAL ONCOLOGY at Kidwai memorial institute of oncology (JAN 2023 – JAN 2026)
Experience
  • Associate Consultant, Apollo hospitals, Bannerghatta Road, Bengaluru (From Feb 2026)
  • RNT Medical College – Senior resident, Udaipur, Rajasthan, India (From July 2021 till July 2022)
  • Raichur institute of medical sciences – Internship, Raichur, Karnataka, India (From March 2016 till March 2017)
Publications
  • A study to investigate the correlation between non-invasive markers of liver fibrosis and cirrhosis (APRI, MELD and Child Pugh Score)
  • Prevalence of thyroid dysfunction in patients with chronic obstructive pulmonary disease: A Single Centre Study
  • Platelet indices and their correlation with hba1c and association with microvascular complications in Type-2 diabetes mellitus
  • Comparison Of Red Cell Distribution Width (RDW) And Apache II Score as prognostic markers among patients with sepsis and septicshock in a Tertiary Care Institute, Southern Rajasthan
  • Study on the significance of BRAF V600E mutations in melanoma patients at a tertiary cancer care centre in Southern India Role of pre-treatment Pan immune inflammation value as predictor marker of response to neoadjuvant therapy in locally advanced rectal cancer: A prospective observational study in tertiary care centre Can ferritin be a surrogate marker for CD4 cells in human immunodeficiency virus patients? A cross‑sectional study of association of serum ferritin levels with immunological staging of human immunodeficiency virus patients